NCT00370045View on ClinicalTrials.gov

Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin

PHASE4UnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 31, 2006

Conditions
Coronary Artery Disease
Interventions
DRUG

Bivalirudin with and without eptifibatide

Trial Locations (1)

21215

RECRUITING

Sinai Hospital, Baltimore

Sponsors

Lead Sponsor

LifeBridge Health
All Listed Sponsors
lead

LifeBridge Health

OTHER

NCT00370045 - Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin | Biotech Hunter | Biotech Hunter